Bindu Hegde, PhD
Email: bindu.hegde@ucsf.edu
2006-2008 Master of Science, Medical Biotechnology; Manipal University, India
2008-2012 Research Associate, Piramal Life Sciences Ltd., Mumbai, India
2012-2018 Ph.D. in Immunology, Laboratory of Dr. Haribabu Bodduluri; University of Louisville
2018-now Postdoctoral Scholar, Laboratory of Dr. Hideho Okada; UCSF
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.
Chuntova P, Downey KM, Hegde B, Almeida ND, Okada H.
Front Immunol. 2019 Jan 22;9:3062. doi: 10.3389/fimmu.2018.03062. eCollection 2018. Review.
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway.
Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M, Langille MGI, Douglas GM, Cheng X, Rouchka EC, Waigel SJ, Dryden GW, Alatassi H, Zhang HG, Haribabu B, Vemula PK, Jala VR.
Nat Commun. 2019 Jan 9;10(1):89. doi: 10.1038/s41467-018-07859-7.
Inflammasome-Independent Leukotriene B4 Production Drives Crystalline Silica-Induced Sterile Inflammation.
Hegde B, Bodduluri SR, Satpathy SR, Alghsham RS, Jala VR, Uriarte SM, Chung DH, Lawrenz MB, Haribabu B.
J Immunol. 2018 May 15;200(10):3556-3567.
Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth.
Satpathy SR, Jala VR, Bodduluri SR, Krishnan E, Hegde B, Hoyle GW, Fraig M, Luster AD, Haribabu B.
Nat Commun. 2015 Apr 29;6:7064.